SKB410 for Injection in Solid Tumors

Clinical trial NCT05906537 · COMPLETED

Trial details

NCT number: NCT05906537
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-07-06
Primary completion: 2026-03-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.